Noted investor and GeneDx board member Eli Casdin has his hedge fund, Casdin Capital, buying up shares of GeneDx Holdings (NASDAQ:WGS).
In the first few days of June, Casdin Capital bought 200,000 shares for about $11.1 million, according to a SEC Form 4 filing
The purchase comes after buying 500,000 shares in May for nearly $21.5 million, according to filings. Transaction summary Transaction value based on SEC Form 4 weighted average purchase prices reported in May and June. Key questions – What proportion of Casdin Capital, LLC’s holdings was involved in this purchase?
May’s 500,000-share acquisition represented nearly 17% of the entity’s total holdings at the time, with the majority classified as indirect ownership through fund structures. The June purchases represent about 6% of Casdin’s holdings entering the month. – How does the current transaction compare in size to Casdin Capital, LLC’s historical trading activity? This is the only purchase of this magnitude in the recent period, aligning with the maximum trade size recorded in the structured history, and capacity data indicate that prior higher-volume activity was possible when larger holdings were available. – What is the resulting ownership structure post-transaction?